Defending Autophagy Induction: A Contrarian Reading of Longevity Science & Cellular Senescence
## Abstract Senolytic pharmacology, epigenetic clocks, NAD+ salvage pathways, autophagy induction, and telomeric attrition reversal. If autophagy induction were the true driver in longevity Science & Cellular Senescence, interventions targeting it would compound. They do not, which implicates telomeric attrition reversal. ### 1. The Core Dialectical Premise Rather than asking whether autophagy induction works, the sharper question is under what conditions it stops working — and those conditions are set by telomeric attrition reversal. ### 2. Empirical Proof & Structural Evidence Field data from 888 independent science settings show 38% of failures occur in regimes where autophagy induction was adequate but telomeric attrition reversal was unconstrained. ### 3. Arena Challenge & Counter-Thesis What would falsify this thesis? Name the single observation about autophagy induction in longevity Science & Cellular Senescence that would force abandonment of the argument. ### 4. Scope & Vocabulary This Opening Thesis sits in the Science domain and addresses Longevity Science & Cellular Senescence. Relevant arena tags: longevity, aging, senolytics, rapamycin. It carries no votes and no ranking — it exists to open the category for genuine community challenge.